The effects of progesterone and progestins on endometrial proliferation

This publication has 17 references indexed in Scilit:

• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
  JAMA, 1995
• Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
  American Journal of Obstetrics and Gynecology, 1994
• Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes
  Fertility and Sterility, 1993
• The role of progestins in hormone replacement therapy
  American Journal of Obstetrics and Gynecology, 1992
• Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study
  British Journal of Cancer, 1989
• Gynecologic consequences of long-term, unopposed estrogen replacement therapy
  Maturitas, 1988
• Endometrial Cancer and Combined Oral Contraceptives
  International Journal of Epidemiology, 1988
• Prevention of endometrial cancer with progestogens
  Maturitas, 1986
• Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study
  Published by American Medical Association (AMA) ,1983
• Endometrial disease after treatment with oestrogens and progestogens in the climacteric.
  BMJ, 1980